The use of indocyanine green to detect sentinel nodes in breast cancer: A prospective study

European Journal of Surgical Oncology

Volumn 41, Issue 1, 2015, Pages 64-70

  Samorani, D ^a,c   Fogacci, T ^a   Panzini, I ^b   Frisoni, G ^a   Accardi, F G ^a   Ricci, M ^b   Fabbri, E ^b   Nicoletti, S ^b   Flenghi, L ^a   Tamburini, E ^b   Tassinari, D ^b   Gianni, L ^b  

^a General Surgery Unit Santarcangelo di Romagna Hospital   (Italy)

^b Hospital of Rimini   (Italy)

^c AUSL Area Vasta Romagna Rimini UO Chirurgia Generale Ospedale Santarcangelo di Romagna   (Italy)

Author keywords

Breast cancer surgery; Indocyanine green; Sentinel node

Indexed keywords

INDOCYANINE GREEN; FLUORESCENT DYE; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; EARLY CANCER; FEMALE; FUNDUS CAMERA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; BREAST NEOPLASMS; CARCINOMA; COHORT ANALYSIS; DIAGNOSTIC USE; LYMPH NODE; MASTECTOMY; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEGMENTAL MASTECTOMY; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; COHORT STUDIES; FEMALE; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; LYMPH NODES; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 84922507356     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.10.047     Document Type: Article

References (34)

1. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;28(349):1864-7.
2. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol 1996;62: 75-7.
3. Glechner A, Wockel A, Gartlehner G, et al. Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: A systematic review and meta-analysis. Eur J Cancer 2013;49:812-25.
4. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer. J Clin Oncol 2005;23: 7703-20.
5. Hindie E, Groheux D, Espie M, et al. Sentinel node biopsy in breast cancer. Bull Cancer 2009; 96:713-25.
6. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011;305: 569-75.
7. Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 2014;32: 1365-83.
8. Donker M, Straver ME, van Tienhoven G, et al. Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. Eur J Cancer 2013;49(9):2093-100.
9. Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial. Lancet Oncol 2013;14(4):297-305.
10. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189(2): 236-9.
11. Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: A systematic review. Lancet Oncol 2014;15(8):e351-62.
12. Chi C, Ye J, Ding H, et al. Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation. PLoS One 2013;8(12):e83927.
13. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H. Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 1999;9:604-7.
14. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 2005;12:211-5.
15. Aoyama K, Kamio T, Ohchi T, Nishizawa M, Kameoka S. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol 2011;9:157.
16. Xiong L, Gazyakan E, Yang W, et al. Indocyanine green fluorescenceguided sentinel node biopsy: A meta-analysis on detection rate and diagnostic performance. Eur J Surg Oncol 2014;40:1027.
17. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001;42:1198- 215.
18. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005;35: 116-28.
19. Buscombe J, Paganelli G, Burak ZE, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007;34: 2154-9.
20. Hindie E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espie M. The sentinel node procedure in breast cancer: nuclear medicine as the starting point. J Nucl Med 2011;52:405-14.
21. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013;24(9):2206-23.
22. Gold HT, Do HT, Osborne MP. Cost-effectiveness of isosulfan blue vs. methylene blue dye in sentinel node biopsy. J Clin Oncol 2005;23: 6103.
23. East JM, Valentine CS, Kanchev E, Blake GO. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: A prospective tabular cumulative sum (CUSUM) analysis. BMC Surg 2009;9:2.
24. Lee JH, Chang CH, Park CH, Kim JK. Methylene blue dye-induced skin necrosis in immediate breast reconstruction: evaluation and management. Arch Plast Surg 2014;41(3):258-63.
25. Mathelin C, Croce S, Brasse D, et al. Methylene blue dye, an accurate dye for sentinel lymph node identification in early breast cancer. Anticancer Res 2009;29(10): 4119-25.
26. Hirche C, Mohr Z, Kneif S, Murawa D, Hunerbein M. High rate of solitary sentinel node metastases identification by fluorescenceguided lymphatic imaging in breast cancer. J Surg Oncol 2012;105: 162-6.
27. Tagaya N, Aoyagi H, Nakagawa A, et al. A novel approach for sentinel lymph node identification using fluorescence imaging and image overlay navigation surgery in patients with breast cancer. World J Surg 2011;35:154-8.
28. Lucci A, McCall LM, Beitsch PD, et al. American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007 20;25: 3657-63.
29. Van der Pas MH, Ankersmit M, Stockmann HB, et al. Laparoscopic sentinel lymph node identification in patients with coloncarcinoma using a near-infrared dye: description of a new technique and feasibility study. J Laparoendosc Adv Surg Tech A 2013;23:367-71.
30. Ballardini B, Santoro L, Sangalli C, et al. The indocyanine green method is equivalent to the 99m Tc-labeled radiotracer method for identifying the sentinel node in breast cancer: A concordance and validation study. Eur J Surg Oncol 2013;39:1332-6.
31. Kitai T, Kawashima M. Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer 2012;19:343-8.
32. Verbeek FP, Troyan SL, Mieog JS, et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer: A multicenter experience. Breast Cancer Res Treat 2014;143:333-4.
33. Schaafsma B, Verbeek FP, Peters AA, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: A randomised comparison of lymphatic tracers. BJOG 2013;120:758-64.
34. Van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m)technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol 2012;19(13):4104-11.